Covid-19: Nursing homes to face action by BMC

In a statement issued by BMC that it will issue notices to around 25% of the total 1,496 nursing homes in the city asking them why the nursing homes should not lose their licenses.

The Brihanmumbai Municipal Corporation (BMC) will issue suspension license notices to 428 nursing homes that remained shut despite repeated warnings and advisories from authorities to keep clinics open to treat non-Covid-19 patients.

Last week, Municipal commissioner Praveen Pardeshi had directed the public health department to issue advisories and guidelines to reopen nursing homes and private clinics.

BMC had also warned housing societies to not object to reopening of private clinics in their premises and had also requested private clinics to practise tele-medicine facility, if possible. Thousands of citizens are not getting medical aid and treatment for non-Covid-19 ailments as many private clinics, nursing homes have shut shop.

The authorities has also decided to set up additional 500 beds for quarantine and isolation facilities in Bandra-Kurla Complex (BKC) at MMRDA grounds. The civic body has also set up a 1,200-bedded quarantine facility at Nesco exhibition centre, Goregaon (East). Out of the 1,200 beds, around 1,000 beds will have oxygen support attached to the beds.

  • Related Posts

    Diabetic drug metformin found to act on brain

    NEW DELHI:  Cheap, effective and widely trusted, metformin has long been the first choice for treating type 2 diabetes. Now, scientists say the drug works in a way few had…

    Hetero debuts semaglutide generic in emerging markets

    New Delhi: Hyderabad-based drugmaker Hetero has announced the launch of its generic semaglutide portfolio in emerging international markets. In a phased global push, the company plans to roll out its…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Diabetic drug metformin found to act on brain

    Diabetic drug metformin found to act on brain

    Hetero debuts semaglutide generic in emerging markets

    Hetero debuts semaglutide generic in emerging markets

    LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

    LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

    Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

    Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

    Stem cell therapy for autism illegal: NMC advisory

    Stem cell therapy for autism illegal: NMC advisory

    India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework

    India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework